LATEST ALERTS
The report analyses enacted law and proposed bills that require tobacco products and e-cigarettes to be included in the tobacco directories before they can be distributed or sold in US states
Extreme vagueness has got the US Food and Drug Administration (FDA) off the hook in the latest major challenge on its handling of premarket tobacco product applications (PMTAs)
As the promised axe has fallen on the workforce at the US Food and Drug Administration (FDA) Center for Tobacco Products (CTP), what comes next for the agencies and the industry?
US president Donald Trump’s tariffs could actively harm public health – but not in a way that might be expected
The US Food and Drug Administration (FDA) recently highlighted the success of its Real Cost public health campaign in preventing youth e-cigarette uptake with the first study to consider the campaign’s impact on e-cigs specifically
Martin Makary faces a vote before the Senate Health, Education, Labor and Pensions Committee today, 13th March. If approved, he takes a step closer to becoming head of the US FDA
US HSS decision-makers have been shuttling staff between employment and dismissal, much like the Grand Old Duke of York in a nursery rhyme marches troops up and down a hill
Packaging of US nicotine alternatives could face a major shake-up, thanks to First Amendment challenges against restrictions on what companies can say and do
Tariffs on Chinese imports will not create any impetus for domestic production in the vaping sector, according to the American Vapor Manufacturers Association (AVM)
This report examines the US Food and Drug Administration (FDA) enforcement measures taken in relation to unauthorised tobacco products, and analyses the warning letters sent out throughout 2024
The first fiery hearing for the confirmation of Robert F Kennedy Jr. as US secretary of health and human services went on with plenty of fireworks but little of substance for the nicotine alternatives industry
Altria released its fourth-quarter and full-year financial results today, revealing progress and ongoing challenges in its business strategy – particularly concerning the acquisition of its e-cigarette brand, Njoy
The US FDA vs RJ Reynolds case at the Supreme Court brought up an important point: the FDA believes vaping could save lives, as it represents a less risky product on a continuum of risk
Nicotine alternatives have gone unmentioned through the initial flurry of actions taken after the inauguration of US president Donald Trump, but several executive orders and proposals will have an impact on the sector
In something of a disconnect in US public health policy, the proposal for a rule to limit the nicotine content for most combustible tobacco products represents a major change from years of prior decisions
The US Food and Drug Administration’s proposed rule to slash nicotine levels in combusted tobacco products has cleared White House review, although it is still far from certain that the rule will come into force
The year 2025 is shaping up to be a significant one for vaping. ECigIntelligence predicts several long-anticipated policy developments will start to emerge as regulators attempt to catch up to the rapidly evolving vaping market
“Disposables” was once again the word of the year in vaping – more specifically for 2024, “a ban on disposables” was the phrase of the year in the sector, with many governments passing prohibition laws in an effort to protect youth and the environment
Interest from the nicotine-alternatives industry in US president-elect Donald Trump’s pick for Food and Drug Administration (FDA) commissioner, Martin Makary, is less about who he is and more about who he is not
This report tracks and analyses the challenges brought to court by vape companies of their marketing denial orders (MDOs) of their premarket tobacco product applications (PMTAs)
Talking about the future of the novel nicotine sector in the United States – its biggest single market by a long way – just got a whole lot harder
November will mark ten years since Iqos was launched in Japan. And as the third-quarter results of Philip Morris International show, the last ten years have been quite the story in the product’s global brand-building
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
